GlassScriptPhysician profile
Megan N Lodeiro
NPI 1518348911
$13,423.14
in general payments reported to CMS, 2019-2025
17 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $44.50 · 2021: $71.64 · 2022: $9,837 · 2023: $2,029 · 2024: $437 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,750 · Food and Beverage: $1,089 · Travel and Lodging: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,750.00 |
| Food and Beverage | $1,088.50 |
| Travel and Lodging | $631.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,378.28 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $415.06 | 2024-2025 | Endurant Iis, Hawkone, Parietene Ds |
| Novo Nordisk INC | $144.21 | 2022-2024 | Wegovy |
| Conmed Corporation | $96.35 | 2023 | Airseal |
| Olympus America INC. | $77.24 | 2021-2024 | 4k Cable 8.5m |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.82 | 2024-2025 | Lifevest |
| Boston Scientific Corporation | $44.50 | 2020 | |
| Intra-Sana Laboratories | $35.50 | 2022-2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Endo Pharmaceuticals INC. | $31.49 | 2021-2023 | Nascobal |
| Microline Surgical INC | $24.52 | 2025 | |
| Daiichi Sankyo INC. | $17.86 | 2023 | Injectafer |
| Phathom Pharmaceuticals, INC. | $16.38 | 2024 | Voquezna |
| Teleflex LLC | $16.17 | 2023 | Titan Sgs Standard Gastric Stapler |
| Amgen INC. | $15.29 | 2022 | |
| Lilly USA, LLC | $14.80 | 2024 | Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $12.92 | 2023 | |
| Redhill Biopharma INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Lodeiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.